Overtreatment of men with prostate cancer and limited life expectancy (LE) has persisted in the era of active surveillance and worsened in some instances, according to a new study. “Overtreatment of ...

Advances in technology have made active surveillance in men with prostate cancer possible and prevented treatment for men who don’t need it, said Matthew Nielsen, MD, FACS, chair, Department of ...

A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators offers new evidence that dietary changes may help reduce cancer cell growth in patients undergoing active surveillance, ...

Clinicians must appropriately assess life expectancy and take steps to avoid prostate cancer overtreatment. Even in the active surveillance era, overtreatment persists among men with limited life ...

Credit: Thinkstock Investigators report beneficial effects of aerobic high-intensity training on cardiometabolic biomarkers. Men on active surveillance for prostate cancer who participated in aerobic ...

The rate of active surveillance as initial treatment increased from 2.0% in 2010 to 8.6% in 2020. The use of active surveillance in patients with intermediate-risk prostate cancer has increased in ...

Active surveillance for low-risk prostate cancer, which involves forgoing immediate treatment, has increased threefold since such "conservative" management was recommended by major guidelines in the ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...

Please provide your email address to receive an email when new articles are posted on . A diet with reduced omega-6 and increased omega-3 fatty acids could slow progression of prostate cancer. The ...

For decades, men with prostate cancer were routinely advised against testosterone replacement therapy (TRT), even if they had ...